KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Net Margin (2016 - 2025)

Historic Net Margin for Pfizer (PFE) over the last 17 years, with Q2 2025 value amounting to 0.17%.

  • Pfizer's Net Margin rose 400.0% to 0.17% in Q2 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.02% for FY2024, which is 400.0% up from last year.
  • According to the latest figures from Q2 2025, Pfizer's Net Margin is 0.17%, which was up 400.0% from 0.05% recorded in Q3 2024.
  • In the past 5 years, Pfizer's Net Margin ranged from a high of 0.17% in Q2 2025 and a low of 1.25% during Q3 2021
  • For the 5-year period, Pfizer's Net Margin averaged around 0.13%, with its median value being 0.03% (2022).
  • Per our database at Business Quant, Pfizer's Net Margin plummeted by -103000bps in 2021 and then surged by 13700bps in 2022.
  • Over the past 5 years, Pfizer's Net Margin (Quarter) stood at 0.05% in 2021, then plummeted by -72bps to 0.09% in 2022, then plummeted by -716bps to 0.76% in 2023, then soared by 94bps to 0.05% in 2024, then skyrocketed by 478bps to 0.17% in 2025.
  • Its Net Margin stands at 0.17% for Q2 2025, versus 0.05% for Q3 2024 and 0.13% for Q2 2024.